Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:HSM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHSMHelius Medical TechnologiesC$0.00C$14.26▼C$40.00C$42.54MN/A3,578 shs930 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHSMHelius Medical Technologies0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHSMHelius Medical TechnologiesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHSMHelius Medical Technologies 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHSMHelius Medical TechnologiesC$477K0.00N/A5.71C$3.61 per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHSMHelius Medical TechnologiesN/A-C$11.02N/AN/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHSMHelius Medical TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHSMHelius Medical Technologies0.744.203.58Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHSMHelius Medical TechnologiesN/AInsider OwnershipCompanyInsider OwnershipHSMHelius Medical TechnologiesN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHSMHelius Medical Technologies192.32 millionN/ANot OptionableNTBR, TON, HSM, and LIFS HeadlinesRecent News About These CompaniesHelius Medical Secures Continued Nasdaq Listing After Compliance WinJuly 11, 2025 | msn.comHelius Medical Technologies Achieves Nasdaq Bid Price ComplianceJune 4, 2025 | msn.comHelius joins BCI landscape with new subsidiaryMarch 14, 2025 | msn.comHelius Medical Secures First Insurance Reimbursement for PoNS DeviceMarch 13, 2025 | msn.comHelius Medical faces Nasdaq delisting over bid priceFebruary 8, 2025 | msn.comHelius Medical files to sell 6.21M shares of common stock for holdersJanuary 31, 2025 | markets.businessinsider.comHelius Medical announces statistically significant find in DGI in PoNSTEP studyJanuary 23, 2025 | markets.businessinsider.comHelius Medical Technologies Inc (HSDT) Stock: Understanding Its Underlying ValueJanuary 16, 2025 | bovnews.comBHelius Medical Achieves Key Milestone with First PoNS System Sale to VADecember 27, 2024 | msn.comWhy Helius Medical Technologies Inc (HSDT) Stock is Currently 64.96% Above from Its 20-Day SMA?December 23, 2024 | bovnews.comBNewtown-based Helius Medical Technologies Explores ‘Strategic Alternatives’ to Boost Stockholder ValueNovember 23, 2024 | msn.comHelius Medical announces exploration of strategic alternativesNovember 19, 2024 | markets.businessinsider.comHelius Medical Technologies Challenges CMS Over PoNS Payment RatesOctober 16, 2024 | msn.comHelius Medical Tech (NASDAQ:HSDT) Stock, Insider Trading ActivityOctober 10, 2024 | benzinga.comHelius Medical Tech (NASDAQ:HSDT) Stock, Short Interest ReportOctober 10, 2024 | benzinga.comHelius Medical Technologies Announces Equity Awards Under 2021 Inducement PlanAugust 17, 2024 | msn.comHelius Medical Technologies, Inc. (NASDAQ:HSDT) Q2 2024 Earnings Call TranscriptAugust 13, 2024 | msn.comWhy Helius Medical Technologies Inc (NASDAQ:HSDT) Stock Decreased -7.43 percent in recent Trade?May 21, 2024 | bovnews.comBHelius Medical Technologies to Unveil Q1 2024 Results and Discuss PoNS® U.S. CommercializationMay 12, 2024 | msn.comHelius Medical Technologies (HSDT) Price Target Decreased by 9.73% to 15.78April 17, 2024 | msn.comMedia Sentiment Over Time Top HeadlinesView All HeadlinesQuantum Gold Rush: The Catalysts Driving Quantum Stocks HigherBy Jeffrey Neal Johnson | July 25, 2025Why Lucid’s 36% Rally on Uber Deal Could Be a Game-ChangerBy Leo Miller | July 22, 20254 Stocks Planning to Substantially Boost Buybacks After Solid Q2By Leo Miller | July 28, 2025Kratos Defense Is Changing Warfare—Here’s What’s Driving ItBy Jeffrey Neal Johnson | July 24, 2025Tesla Teams With Samsung—Will Other Chipmakers Follow?By Gabriel Osorio-Mazilli | August 1, 2025NTBR, TON, HSM, and LIFS Company DescriptionsHelius Medical Technologies TSE:HSMHelius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Intel's White House Reset: From Political Storm to a Clearer Sky AST SpaceMobile on Track for Explosive Upside Oklo’s Stock Is Set up for a Correction—Buy It When It Bounces If Qualcomm Holds $145, Its Next Move Could Be Massive Alphabet Reclaims $200 Threshold—Bull Run Reignited? NFL and WWE Land on ESPN—The Impact on Disney and TKO Stocks Brutal 2025 for Sarepta—Analysts Still Call for 179% Upside Apple & Trump: $100B Investment, Tariffs News Push Shares Up 13% Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access